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Modulation of allergic dermatitis
An absence of immunological tolerance to haptens char-
acterizes allergic contact dermatitis. Using the cutaneous 
contact hypersensitivity model for this disease, Karsak and 
colleagues implicated the cannabinoid receptors CB1 and 
CB2, which are heterotrimeric GTP-binding protein-cou-
pled receptors, in allergic inflammation. Upon exposure 
to the obligate contact allergen 2,4-dinitrofluorobenzene, 
double knockout (Cnr1-/-/Cnr2-/-) mice exhibited increased 
infiltration of granulocytes and major histocompatibility II+ 
antigen-presenting cells. Similar effects were observed in 
the single knockout mice, suggesting a nonredundant role 
for each cannabinoid receptor in this model. In addition, 
pharmacologic blockade of the cannabinoid receptors 
enhanced contact allergic inflammation, whereas stimula-
tion of these receptors via administration of cannabinoids 
(Δ9-THC) attenuated the allergic response. Thus, modula-
tion of the endocannabinoid system, which clearly serves a 
protective role in contact allergy, offers a promising avenue 
for therapy development for allergic contact dermatitis. 
(Science 316:1494–7, 2007)
Battle against the superantigens
Superantigens (SAgs), which are produced primarily by 
Staphylococcus aureus and Streptococcus pyogenes, bind 
to the variable (Vβ) regions of T-cell receptors. This bind-
ing may activate T cells and initiate a systemic release of 
inflammatory cytokines known as toxic shock syndrome. 
Recently, Buonpane and colleagues engineered high-affini-
ty receptor antagonists to neutralize the SAg staphylococcal 
enterotoxin B (SEB) using directed evolution of Vβ via yeast 
display. The binding affinities of these antagonists were in 
the picomolar range, and these molecules were capable of 
neutralizing SEB-reactive T cells. Furthermore, experiments 
in rabbits indicated that these Vβ molecules effectively 
neutralized the activity of SEB better than the conventional 
intravenous immunoglobulin when administered after the 
toxin had induced elevated temperatures or in the pres-
ence of continuous SEB delivery. Successful engineering of 
effective high-affinity neutralizing Vβ molecules provides 
an optimistic future for tailoring a specific Vβ therapy to all 
the different toxins present in an individual staphylococcal 
and streptococcal infection. (Nat Med 13:725–9, 2007)
ARF: independent tumor suppressor
The aggressive and potentially fatal nature of cutaneous 
malignant melanoma underscores the necessity of under-
standing the genetic and environmental mechanisms of the 
disease. The INK4A-ARF locus, which is often deleted or 
inactivated in melanoma, has been implicated in suppres-
sion of melanoma. Although ARF (p14ARF) was previously 
thought to function primarily as a positive regulator of the 
p53 tumor suppressor, Ha and colleagues recently uncov-
ered a role for this protein independent of p53. In primary 
melanocytes, ARF regulated senescence via a mechanism 
distinct from p53 and Ink4a. Loss of Arf in these cells 
conferred a selective growth advantage relative to loss of 
p53 or Ink4a, and restoration of Arf via retroviral expres-
sion resulted in cellular growth arrest and senescence. 
Interestingly, mutant neuroblastoma Ras viral oncogene in 
conjunction with the loss of Arf, but not inactivation of p53 
alone, readily permitted the formation of tumors by mela-
nocytes. Thus, ARF functions as a melanoma tumor sup-
pressor via a p53-independent mechanism of senescence. 
As a result, altering the functions of ARF separately from 
p53 may serve as a potent therapeutic target for melanoma 
patients. (Proc Natl Acad Sci USA 104:10968–73, 2007)
Amazing reprogramming of 
differentiated cells
A major goal in stem cell research has been to directly 
reprogram fetal cells to a pluripotent embryonic stem (ES) 
cell-like state, especially in light of the recent excessive 
media and congressional attention to embryonic stem cell 
work. Two independent groups retrovirally expressed the 
four transcription factors, Oct4, Sox2, c-Myc, and Klf4, 
in mouse embryonic fibroblasts. ES cell-like clone selec-
tion was based on activation of the well-known pluripo-
tency markers Nanog or Oct4. The DNA methylation, gene 
expression, and chromatin configuration of these cells 
mimicked those of ES cells. Following injection into early 
mouse embryos, these reprogrammed cells were found 
throughout the body. Strikingly, Wernig and colleagues 
injected the reprogrammed cells into tetraploid blastocysts 
and found that all the lineages of the resultant embryos 
were established in a developmentally appropriate man-
ner. In addition, Okita and colleagues reported that 20% of 
chimeric mice developed tumors that resulted directly from 
reactivation of the c-myc transgene in the reprogrammed 
cells. Additional experiments from Wernig and colleagues 
suggested that initiation of the pluripotent state of these 
reprogrammed cells stems from the virally transduced fac-
tors; however, this state is maintained largely by the activity 
of the endogenous factors. Thus, retroviral vectors, which 
can wreak havoc on the genome of the cells, are not neces-
sary for long-term delivery of this activity, and other mech-
anisms for activating critical factors such as adenoviral vec-
tors or small-molecule chemicals may be feasible alterna-
tives for use in humans in the future. (Nature 448:313–7, 
2007; Nature 448:318–24, 2007)
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